|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,629.00 GBX | -2.16% |
|
-1.42% | +6.64% |
| 01:49pm | Germany risks missing out on new drugs, AstraZeneca CEO tells paper | RE |
| 10:55am | AstraZeneca says Ultomiris meets primary endpoint in phase III trial | AN |
Chart calendar AstraZeneca PLC
Upcoming events on AstraZeneca PLC
| 29/04/2026 | Earnings release - Q1 2026 | Day |
| 29/04/2026 | Earnings presentation | 11:00 |
| 27/07/2026 | Earnings release - Q2 2026 | ~ 08:00 |
Past events on AstraZeneca PLC
| 09/04/2026 | Annual General Meeting | 15:30 |
| 09/04/2026 | Présentation aux Actionnaires / Analystes | 14:30 |
| 10/02/2026 | Earnings release - Q4 2025 | ~ 07:00 |
| 10/02/2026 | Earnings presentation | 11:45 |
| 18/11/2025 | Information meeting | Day |
| 06/11/2025 | Earnings release - Q3 2025 | 07:00 |
| 06/11/2025 | Earnings presentation | 13:00 |
| 03/11/2025 | Présentation aux Actionnaires / Analystes | 14:30 |
| 03/11/2025 | Extraordinary General Meeting | Day |
| 29/07/2025 | Earnings release - Q2 2025 | 07:00 |
| 29/07/2025 | Earnings presentation | 14:00 |
| 28/05/2025 | Information meeting | 13:00 |
| 29/04/2025 | Earnings release - Q1 2025 | ~ 08:00 |
| 29/04/2025 | Earnings presentation | 11:45 |
Past dividends on AstraZeneca PLC
| 19/02/2026 | Ex-dividend date - 1.595 GBX | 05:00 |
| 07/08/2025 | Ex-dividend date - 0.767 GBX | 05:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 45 811 45 716 0.21% | 54 073 53 340 1.37% | 58 739 58 800 -0.1% | 63 179 | 67 084 | 71 661 |
|
EBITDA Million USD | Released Forecast Spread | 13 580 15 477 -12.26% | 16 691 16 909 -1.29% | 19 476 19 668 -0.98% | 22 359 | 24 754 | 27 282 |
|
EBIT Million USD | Released Forecast Spread | 14 534 15 036 -3.34% | 16 928 17 034 -0.63% | 18 478 18 819 -1.81% | 21 161 | 23 617 | 26 090 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6 899 9 269 -25.57% | 8 691 10 318 -15.77% | 12 402 12 888 -3.77% | 15 785 | 18 471 | 20 986 |
|
Net income Million USD | Released Forecast Spread | 5 961 6 597 -9.64% | 7 035 8 172 -13.91% | 10 225 10 070 1.54% | 12 500 | 14 112 | 16 163 |
|
EPS USD | Released Forecast Spread | 3,81 4,34 -12.22% | 4,50 5,33 -15.6% | 6,54 6,34 3.11% | 7,93 | 9,00 | 10,4 |
| Announcement Date | 08/02/24 | 06/02/25 | 10/02/26 | - |
Quarterly results
| Fiscal Period | December | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 12 938 12 528 3.28% | 25 617 12 560 103.96% | 13 565 13 102 3.53% | 14 891 14 181 5.01% | 13 588 13 741 -1.11% | 14 457 14 095 2.57% | 15 191 14 769 2.86% | 15 503 15 371 0.86% | 14 922 | 15 375 | 16 163 | 16 675 | 15 550 | 16 215 | 17 215 | 17 635 |
|
EBITDA Million USD | Released Forecast Spread | 4 025 4 305 -6.51% | 3 923 4 265 -8.01% | 4 373 5 435 -19.54% | 4 958 5 324 -6.87% | 4 897 4 284 14.31% | 5 132 4 936 3.97% | 4 489 6 081 -26.18% | 5 811 | 5 781 | 6 009 | 5 971 | |||||
|
EBIT Million USD | Released Forecast Spread | 4 101 4 016 2.11% | 8 411 4 052 107.58% | 4 318 4 177 3.37% | 4 199 4 300 -2.34% | 4 803 4 583 4.81% | 4 584 4 495 1.99% | 4 993 4 753 5.05% | 4 098 4 383 -6.51% | 5 168 | 5 124 | 5 620 | 5 302 | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 397 2 395 0.08% | 1 828 2 873 -36.37% | 1 666 2 825 -41.03% | 3 127 2 874 8.8% | 3 244 3 487 -6.97% | 3 556 | 3 890 | 4 717 | 3 958 | |||||||
|
Net income Million USD | Released Forecast Spread | 1 927 2 130 -9.52% | 1 429 2 332 -38.72% | 1 500 3 284 -54.32% | 2 916 2 458 18.63% | 2 450 2 497 -1.87% | 2 533 2 782 -8.94% | 2 326 2 801 -16.95% | 3 148 | 3 134 | 3 607 | 3 238 | |||||
|
EPS USD | Released Forecast Spread | 1,24 1,36 -9% | 0,91 1,49 -39.13% | 0,96 2,11 -54.44% | 1,88 1,57 19.47% | 1,57 1,66 -5.38% | 1,62 1,78 -9.18% | 1,49 1,80 -17.29% | 2,01 | 2,00 | 2,31 | 2,07 | |||||
| Announcement Date | 25/07/24 | 25/07/24 | 12/11/24 | 06/02/25 | 29/04/25 | 29/07/25 | 06/11/25 | 10/02/26 | - | - | - | - | - | - | - | - |
| 22/04/2026 | Présentation aux Actionnaires / Analystes | 16:00 | |
| 22/04/2026 | Board of Directors Meeting | Day | |
| 22/04/2026 | Earnings release - Q1 2026 | ~ 08:00 | |
| 22/04/2026 | Earnings release - Annual 2025 | ~ 08:00 | |
| 22/04/2026 | Earnings release - Annual 2025 | ~ 02:30 | |
| 22/04/2026 | Earnings release - Q1 2026 | ~ 08:00 | |
| 22/04/2026 | Earnings release - Annual 2025 | ~ 08:00 | |
| 22/04/2026 | Earnings release - Q1 2026 | ~ 08:00 | |
| 22/04/2026 | Extraordinary General Meeting | Day | |
| 22/04/2026 | Earnings release - Q1 2026 | ~ 21:00 |
Past sector events for AstraZeneca PLC
| Today | Earnings release - Annual 2025 | ~ 08:00 | |
| Today | Earnings release - Q1 2026 | ~ 02:30 | |
| Today | Présentation aux Actionnaires / Analystes | 15:00 | |
| Today | Annual General Meeting | 15:00 | |
| Today | Earnings presentation | 08:00 | |
| Today | Earnings release - Annual 2025 | ~ 08:00 | |
| Today | Earnings release - Q1 2026 | ~ 08:00 | |
| Today | Earnings release - Annual 2025 | ~ 02:30 | |
| Today | Earnings release - Q1 2026 | ~ 08:00 | |
| Today | Annual General Meeting | 08:30 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AZN Stock
- Calendar AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















